Connection
Marc Bonaca to United States Food and Drug Administration
This is a "connection" page, showing publications Marc Bonaca has written about United States Food and Drug Administration.
|
|
Connection Strength |
|
 |
|
 |
|
0.029 |
|
|
|
-
Magnani G, Bonaca MP, Braunwald E, Dalby AJ, Fox KA, Murphy SA, Nicolau JC, Oude Ophuis T, Scirica BM, Spinar J, Theroux P, Morrow DA. Efficacy and safety of vorapaxar as approved for clinical use in the United States. J Am Heart Assoc. 2015 Mar 19; 4(3):e001505.
Score: 0.029